UK Urinalysis Market (2024-2029)
The UK Urinalysis Market was valued at $208.8 Million in 2024 and projected to reach to $354.3 Million by 2029, representing a compound annual growth rate of 11.1%. The UK urinalysis market is positioned for sustained expansion through 2029, driven by demographic shifts, increased chronic disease prevalence, and NHS modernisation initiatives.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
UK Urinalysis Market Trends and Insights
- This expansion reflects the UK's increasing demand for diagnostic testing across primary care, hospitals, and specialist laboratories.
- The UK market is driven by rising prevalence of chronic diseases, aging demographics, and enhanced investment in healthcare infrastructure that prioritizes early disease detection through routine urinalysis screening. The UK urinalysis sector benefits from advanced laboratory automation, integration of digital health systems, and strong regulatory frameworks that ensure quality standards.
- Between 2024 and 2029, the UK is expected to see accelerated adoption of point-of-care testing devices and AI-enabled diagnostic platforms.
- The UK's National Health Service (NHS) commitment to preventive medicine and cost-effective diagnostics further supports market expansion, positioning the UK as a key growth market within Europe's broader urinalysis landscape..
Key Market Statistics
- CAGR (2024-2029) 11.1% CAGR
- Market Size, 2024 ~USD 208.8 Million
- Forecast, 2029 ~USD 354.3 Million
- Country UK
UK Urinalysis Market Overview
Market Valuation Growth :
The UK urinalysis market is valued at £208.8 million in 2024, with a strong CAGR of 11.1% projected to reach £354.3 million by 2029, significantly outpacing the global growth rate of 9.6%.
NHS Integration & Primary Care Expansion :
Increased adoption of urinalysis testing across NHS primary care centres and GP practices is driving market growth, supported by enhanced diagnostic protocols and preventative healthcare initiatives across England, Scotland, Wales, and Northern Ireland.
Aging Population & Chronic Disease Burden :
The UK's aging demographic profile and rising prevalence of chronic conditions including diabetes, hypertension, and kidney disease are creating sustained demand for routine urinalysis screening and monitoring across all healthcare settings.
Healthcare Infrastructure Investment :
Significant UK government investment in laboratory automation, point-of-care testing devices, and digital pathology infrastructure is modernising urinalysis capabilities in hospitals and specialist diagnostic centres nationwide.
UK Urinalysis Market Dynamics
- Enhanced funding for diagnostic services and the integration of automated testing platforms in hospital laboratories will accelerate market penetration.
- Primary care expansion and point-of-care testing adoption in community settings will broaden accessibility.
- Regulatory support for advanced diagnostic technologies and growing emphasis on early disease detection will further strengthen market dynamics.
- The UK's commitment to preventative healthcare and digital health integration presents significant opportunities for market players to capture growing demand across diverse healthcare settings..
Related Ecosystem
In Vitro Diagnostics
- Polymerase Chain Reaction (PCR)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Dna Microarrays
- Assay Kits
- Microarrays
- ROCHE HOLDINGS AG
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Abbott Laboratories
- Biomerieux s.a.
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- CONMED Corporation
Key Takeaways
- The UK urinalysis market will grow from £208.8M (2024) to £354.3M (2029), representing 11.1% CAGR.
- The UK's aging population and rising chronic disease prevalence are primary drivers of diagnostic demand.
- The UK market is characterized by strong NHS integration and adoption of automated laboratory technologies.
- Point-of-care testing and AI-enabled diagnostics are expected to accelerate UK market growth through 2029.
Urinalysis Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | HOSPITALS & CLINICS (End User) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 9.6% from 2024 to 2029 |
| Largest Segment | CONSUMABLES (Product) |
| Market Size Base Year (Billions) | ~USD 4.3 (2024) |
| Revenue Forecast (Billions) | ~USD 6.8 (2029) |
| Segments Covered | Product, Type, Test Type, Application, End User |
UK Urinalysis Market Report Segmentation
5 segment dimensions are covered across the global market.
By Product
- Consumables
- Instruments
By Type
- Automated Urine Analyzers
- Biochemical Urine Analyzers
- Brazil
- Diabetes
- Dipsticks
- Disposables
- Flow Cytometry Analyzers
- Integrated Urine Analyzers
- Kidney Diseases
- Laboratory Tests
- Liver Diseases
- Mexico
- Microscopy Analyzers
- Other Disease Screening Applications
- Poc Tests
- Point-Of-Care Urine Analyzers
- Pregnancy & Fertility Kits
- Reagents
- Rest Of Latam
- Sediment Urine Analyzers
- Semi-Automated Urine Analyzers
- Urinary Tract Infections
By Test Type
- Biochemical Tests
- Pregnancy & Fertility Tests
- Sediment Urinalysis
By Application
- Disease Screening
- Pregnancy & Fertility Testing
By End User
- Diagnostic Laboratories
- Home Care Settings
- Hospitals & Clinics
- Research Laboratories & Institutes
UK: URINALYSIS MARKET, BY END USER, 2022–2029
| Segment | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| DIAGNOSTIC LABORATORIES | 69.3 | 73.1 | 78 | 83.9 | 90.9 | 99.6 | 110.3 | 123.4 | 9.6 |
| HOME CARE SETTINGS | 44.4 | 47 | 50.3 | 54.3 | 59.2 | 65.2 | 72.5 | 81.7 | 10.2 |
| HOSPITALS & CLINICS | 55.1 | 60.3 | 66.8 | 74.5 | 83.9 | 95.6 | 110 | 128.2 | 13.9 |
| RESEARCH LABORATORIES & INSTITUTES | 12.4 | 13 | 13.7 | 14.6 | 15.7 | 17.1 | 18.9 | 21 | 8.9 |
| TOTAL | 181.2 | 193.4 | 208.8 | 227.4 | 249.7 | 277.5 | 311.7 | 354.3 | 11.1 |
Target Audience
- In Vitro Diagnostics (IVD) Manufacturers : UK and international urinalysis device and reagent manufacturers need market intelligence to assess growth potential, identify distribution channels, and develop NHS-compliant product strategies for the British market.
- NHS Trusts & Hospital Laboratory Directors : Hospital and laboratory leaders require data on market trends, technology adoption rates, and competitive offerings to optimise procurement decisions and modernise diagnostic capabilities within budget constraints.
- Private Diagnostic & Pathology Providers : Independent and private laboratory operators need UK-specific market insights to identify growth opportunities, benchmark performance, and develop competitive strategies in the expanding private diagnostics sector.
- Healthcare Investment & Private Equity Firms : Investors evaluating UK healthcare diagnostics opportunities require detailed market analysis, growth projections, and competitive dynamics to inform acquisition, partnership, and funding decisions.
- Medical Device Distributors & Suppliers : UK-based distributors and medical suppliers need country-specific market data to forecast demand, optimise inventory, and identify emerging opportunities across NHS and private healthcare channels.
Reasons to Buy this Report
- UK-Specific Market Sizing & Forecasts : Access precise valuation data for the UK urinalysis market with country-specific CAGR of 11.1%, enabling accurate financial planning and investment decisions tailored to the British healthcare landscape.
- NHS & Healthcare System Insights : Understand NHS procurement patterns, primary care integration strategies, and hospital laboratory adoption trends specific to England, Scotland, Wales, and Northern Ireland for targeted market entry.
- Competitive Landscape & Market Positioning : Identify key UK-based and international competitors, their market share, product portfolios, and strategic positioning within the British urinalysis diagnostic sector.
- Growth Driver Analysis for UK Market : Detailed assessment of UK-specific growth catalysts including aging demographics, chronic disease prevalence, healthcare infrastructure investment, and regulatory environment shaping market dynamics.
- Strategic Expansion & Partnership Opportunities : Identify high-potential segments, geographic hotspots, and partnership opportunities with NHS trusts, private laboratories, and diagnostic providers across the UK healthcare ecosystem.
Frequently asked questions
What is the current size of the UK urinalysis market?
The UK urinalysis market was valued at £208.8 million in 2024 and is forecast to reach £354.3 million by 2029.
What is the growth rate of the UK urinalysis market?
The UK urinalysis market is expected to grow at a compound annual growth rate (CAGR) of 11.1% from 2024 to 2029.
What factors are driving growth in the UK urinalysis market?
Key drivers include an aging population, rising prevalence of chronic diseases, NHS investment in preventive diagnostics, and adoption of automated laboratory technologies and point-of-care testing devices.
Which segments are leading the UK urinalysis market?
The UK market is led by hospital laboratories and primary care settings, with growing adoption of point-of-care testing and AI-enabled diagnostic platforms across the healthcare system.
How does the UK urinalysis market compare to Europe?
The UK urinalysis market, growing at 11.1% CAGR, represents a significant portion of the European market and is driven by strong NHS infrastructure and advanced diagnostic capabilities.
RESEARCH METHODOLOGY
The objective of this study is to analyze the key market dynamics, including drivers, opportunities, constraints, challenges, and strategies employed by key players. Developments within companies, such as acquisitions, product launches, expansions, agreements, and partnerships, will be tracked to assess the competitive landscape of the urinalysis market. This analysis will evaluate market players across various parameters within the broader categories of business and product strategy.
To estimate the market size, both top-down and bottom-up approaches were used. The market breakdown and data triangulation were used to determine the sizes of segments and subsegments.
The four steps involved in estimating the market size are:
Secondary Research
In the secondary research process, various secondary sources, including annual reports, press releases and investor presentations from companies, white papers, certified publications, articles by recognized authors, gold- and silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva), were consulted to identify and collect information for this study.
Primary Research
In the primary research process, interviews with sources from both the supply and demand sides were conducted to gather qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries, as well as preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations across all segments of this industry’s value chain. In-depth interviews were conducted with key industry participants, subject-matter experts, C-level executives at key market players, and industry consultants to obtain and verify critical qualitative and quantitative information and to assess prospects.
Note 1: Other designations include sales, marketing, and product managers.
Note 2: Companies are classified into tiers based on their total revenue. As of 2025, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = <USD 10 million.
|
COMPANY NAME |
DESIGNATION |
|
Sysmex Corporation |
Sales Manager |
|
Thermo Fisher Scientific, Inc. |
Sales Executive |
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the urinalysis market. These methods were also used extensively to estimate the size of various market subsegments. The research methodology used to estimate the market size includes the following:
- The key players in the industry have been identified through extensive secondary research.
- The revenue generated by leading players operating in the urinalysis market was determined through primary and secondary research.
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
The research methodology used to estimate the market size includes the following:
Data Triangulation
After determining the overall market size using the process described above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed wherever applicable. The data was triangulated by analyzing various factors and trends from both the demand and supply sides.
Market Definition
Urinalysis is a procedure used to assess the appearance, concentration, and content of urine. It detects and helps manage various disorders, such as urinary tract infections, kidney diseases, diabetes, and other metabolic disorders. The primary urinalysis tests include biochemical and sediment analysis. In this report, we have also discussed pregnancy and fertility tests for urine analysis.
Key Stakeholders
- Manufacturers and Distributors of Urinalysis Products
- Hospitals & Clinics
- Diagnostic Laboratories
- Research Laboratories & Institutes
- Research & Development (R&D) Companies
- Government Associations
- Venture Capitalists and Investors
Report Objectives
- To define, segment, and forecast the urinalysis market by product, test type, application, technology, end user, and region
- To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the market segments with respect to five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
- To profile key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To benchmark players within the market using the proprietary Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business and product excellence
- To study the impact of AI on the market, along with the macroeconomic outlook for each region
Available customizations:
MarketsandMarkets offers the following customizations for this market report.
Country Information
- Additional country-level analysis of the urinalysis market
Company profiles
- Additional five company profiles of players operating in the urinalysis market.
Product Analysis
- Product matrix, which provides a detailed comparison of the product portfolio of each company in the urinalysis market
Get the Full Urinalysis Market Report
Full forecast, segment splits, and company analysis for all Urinalysis Market.
- Canada Urinalysis Market
- US Urinalysis Market
- Germany Urinalysis Market
- France Urinalysis Market
- Italy Urinalysis Market
- Spain Urinalysis Market
- Russia Urinalysis Market
- China Urinalysis Market
- Japan Urinalysis Market
- India Urinalysis Market
- Australia Urinalysis Market
- South Korea Urinalysis Market
- Brazil Urinalysis Market
- Mexico Urinalysis Market
- Rest Of Europe Urinalysis Market
- Rest Of Asia Pacific Urinalysis Market
- Rest Of Latin America Urinalysis Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
